Drugs / Ortho Cyclen (21)
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ORTHO CYCLEN-28 | — | 1989-12-29 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02213029 Background | Aug 2014 → Feb 2016 | — | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ortho Cyclen (21) | “Ortho Cyclen (21) ® is a registered trademark” NCT02213029 ↗ |
| Route | Oral | “tablets for oral administration per product insert” NCT02213029 ↗ |